January 3, 2022
Trulieve Cannabis Corp Wins Dismissal with Prejudice of Securities Fraud Class Action
December 7, 2021
King & Spalding Advises Oaktree Acquisition Corp. II in its Merger with Alvotech
August 24, 2021
Arbor Pharmaceuticals to Merge with Azurity Pharmaceuticals
December 31, 2020
King & Spalding Advises on Landmark Medicare Reform Bills BENES Act and PAID Act, Both Passed By Congress
June 1, 2020
Alexion Pharmaceuticals Secures Favorable Resolution and Termination of Challenge to SOLIRIS® Patents
July 30, 2019
American Clinical Laboratory Association (ACLA) Wins Jurisdictional Decision in D.C. Circuit Court
July 20, 2016
King & Spalding Advises Jounce Therapeutics on Deal Worth Up to $2.5 Billion
March 24, 2016
King & Spalding Represents GSK on Strategic Collaboration with Miltenyi Biotec
September 17, 2015
King & Spalding Advises Nurix in $150 Million-Plus Drug Collaboration and Option Deal with Celgene
June 8, 2015
King & Spalding Team Advises Five Prime Therapeutics in $131 Million License Agreement with bluebird bio